Skip to content

Clinical trials

Vulvar Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Vulvar Neoplasms Clear all

235 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20021
20035
20044
20053
20066
200710
20085
20098
20104
20118
20127
20134
20143
20155
20167
20177
201811
20199
202014
202114
202215
202322
202422
202512
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103
Recruiting49
Unknown status30
Active, not recruiting18
Terminated15
Not yet recruiting12
Withdrawn5
Suspended2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group11
Merck Sharp & Dohme LLC11
M.D. Anderson Cancer Center8
National Cancer Institute (NCI)8
Ohio State University Comprehensive Cancer Center6
Dana-Farber Cancer Institute5
Fondazione Policlinico Universitario Agostino Gemelli IRCCS5
Shanghai Bovax Biotechnology Co., Ltd.5
City of Hope Medical Center4
Memorial Sloan Kettering Cancer Center4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Vulvar Neoplasms235
Uterine Cervical Neoplasms155
Vaginal Neoplasms113
Endometrial Neoplasms73
Ovarian Neoplasms71
Anus Neoplasms46
Fallopian Tube Neoplasms38
Breast Neoplasms31
Penile Neoplasms31
Uterine Neoplasms30

Trials

Showing 26 to 50 of 235. Each trial links to its page on Pharma Observatory.

135 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.